ALZC.F Stock Overview

Develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details

ALZC.F fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	2/6
Past Performance	6/6
Financial Health	6/6
Dividends	3/6

Rewards

Trading at 70.2% below our estimate of its fair value

Earnings are forecast to grow 12.82% per year

Earnings grew by 65.3% over the past year

Analysts in good agreement that stock price will rise by 28.8%

Risk Analysis

Shares are highly illiquid

Unstable dividend track record

My Notes

Capture your thoughts, links and company narrative

AlzChem Group AG Competitors

Valhi

NYSE:VHI

US$677.7m

Ecovyst

NYSE:ECVT

US$876.2m

Chase

NYSEAM:CCF

US$1.2b

Stepan

NYSE:SCL

US$1.6b

Price History & Performance

Summary of share price highs, lows and changes for AlzChem Group
Historical stock prices
Current Share Price	€58.60
52 Week High	€62.07
52 Week Low	€48.49
Beta	0.96
1 Month Change	20.85%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	112.01%
5 Year Change	n/a
Change since IPO	112.01%

Recent updates

Shareholder Returns

	ALZC.F	US Chemicals	US Market
7D	0%	-3.0%	0.1%
1Y	n/a	-0.09%	26.1%

Return vs Industry: Insufficient data to determine how ALZC.F performed against the US Chemicals industry.

Return vs Market: Insufficient data to determine how ALZC.F performed against the US Market.

Price Volatility

Is ALZC.F's price volatile compared to industry and market?
ALZC.F volatility
ALZC.F Average Weekly Movement	n/a
Chemicals Industry Average Movement	5.4%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.7%
10% least volatile stocks in US Market	3.1%

Stable Share Price: ALZC.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ALZC.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1908	1,607	Andreas Niedermaier	www.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
ALZC.F fundamental statistics
Market cap	US$619.53m
Earnings (TTM)	US$52.59m
Revenue (TTM)	US$591.53m

11.7x

P/E Ratio

1.0x

P/S Ratio

Is ALZC.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALZC.F income statement (TTM)
Revenue	€563.55m
Cost of Revenue	€214.74m
Gross Profit	€348.81m
Other Expenses	€298.71m
Earnings	€50.10m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 28, 2025

Earnings per share (EPS)	4.92
Gross Margin	61.90%
Net Profit Margin	8.89%
Debt/Equity Ratio	0%

How did ALZC.F perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

24%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 01:34
End of Day Share Price	2024/12/10 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AlzChem Group AG is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Laura Lopez Pineda	Baader Helvea Equity Research
Konstantin Wiechert	Baader Helvea Equity Research
Knut Woller	Baader Helvea Equity Research